In Vivo Predictive Dissolution and Simulation Workshop Report: Facilitating the Development of Oral Drug Formulation and the Prediction of Oral Bioperformance

Saved in:
Bibliographic Details
Published inThe AAPS journal Vol. 20; no. 6; p. 100
Main Authors Tsume, Yasuhiro, Patel, Sanjaykumar, Fotaki, Nikoletta, Bergstrӧm, Christel, Amidon, Gordon L., Brasseur, James G., Mudie, Deanna M., Sun, Duxin, Bermejo, Marival, Gao, Ping, Zhu, Wei, Sperry, David C., Vertzoni, Maria, Parrott, Neil, Lionberger, Robert, Kambayashi, Atsushi, Hermans, Andre, Lu, Xujin, Amidon, Gregory E.
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 06.09.2018
Subjects
Administration, Oral
Biochemistry
Biomedical and Life Sciences
Biomedicine
Biotechnology
Chemistry, Pharmaceutical
Computer Simulation
Congresses as Topic
dissolution
Drug Development
Drug Liberation
formulation prediction
Gastrointestinal Absorption
Gastrointestinal Contents - chemistry
Humans
Hydrodynamics
Hydrogen-Ion Concentration
in vivo prediction
Meeting Report
Models, Biological
Pharmaceutical Preparations - administration & dosage
Pharmaceutical Preparations - chemistry
Pharmacology/Toxicology
Pharmacy
simulation
Solubility
prediction
formulation prediction
simulation
dissolution
in vivo prediction
Online AccessGet full text

Cover

ArticleNumber 100
Author Fotaki, Nikoletta
Patel, Sanjaykumar
Lu, Xujin
Gao, Ping
Hermans, Andre
Amidon, Gregory E.
Bergstrӧm, Christel
Zhu, Wei
Sun, Duxin
Bermejo, Marival
Lionberger, Robert
Amidon, Gordon L.
Tsume, Yasuhiro
Kambayashi, Atsushi
Sperry, David C.
Parrott, Neil
Brasseur, James G.
Mudie, Deanna M.
Vertzoni, Maria
AuthorAffiliation 1 College of Pharmacy, The University of Michigan, 428 Church Street, Ann Arbor, Michigan 48109, USA
2 Present Address: Merck & Co., Inc., 126 E Lincoln Ave, Rahway, New Jersey 07065, USA
13 Food and Drug Administration, Silver Spring, Maryland 21201, USA
10 Eli Lilly and Company, Indianapolis, Indiana, 46285, USA
12 F. Hoffmann-La Roche, Ltd., Roche Innovation Center, Basel, Switzerland
3 Department of Pharmacy and Pharmacology, University of Bath, Bath, UK
15 Bristol-Myers Squibb Company, New Brunswick, New Jersey 08903, USA
11 Department of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
9 Merck & Co., Inc., West Point, Pennsylvania 19486, USA
14 Astellas Pharma Inc., Shizuoka, Japan
7 Universidad Miguel Hernández de Elche, Elche, Spain
4 Department of Pharmacy, Uppsala University, Uppsala, Sweden
5 Aerospace Engineering Sciences, University of Colorado, Boulder, Colorado, USA
8 Abbvie, Inc., Chicago, Illinois, USA
6 Research and Development, Lonza, Bend, Oregon, USA
AuthorAffiliation_xml – name: 3 Department of Pharmacy and Pharmacology, University of Bath, Bath, UK
– name: 13 Food and Drug Administration, Silver Spring, Maryland 21201, USA
– name: 4 Department of Pharmacy, Uppsala University, Uppsala, Sweden
– name: 9 Merck & Co., Inc., West Point, Pennsylvania 19486, USA
– name: 12 F. Hoffmann-La Roche, Ltd., Roche Innovation Center, Basel, Switzerland
– name: 7 Universidad Miguel Hernández de Elche, Elche, Spain
– name: 1 College of Pharmacy, The University of Michigan, 428 Church Street, Ann Arbor, Michigan 48109, USA
– name: 15 Bristol-Myers Squibb Company, New Brunswick, New Jersey 08903, USA
– name: 6 Research and Development, Lonza, Bend, Oregon, USA
– name: 5 Aerospace Engineering Sciences, University of Colorado, Boulder, Colorado, USA
– name: 2 Present Address: Merck & Co., Inc., 126 E Lincoln Ave, Rahway, New Jersey 07065, USA
– name: 11 Department of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece
– name: 10 Eli Lilly and Company, Indianapolis, Indiana, 46285, USA
– name: 14 Astellas Pharma Inc., Shizuoka, Japan
– name: 8 Abbvie, Inc., Chicago, Illinois, USA
Author_xml – sequence: 1
  givenname: Yasuhiro
  surname: Tsume
  fullname: Tsume, Yasuhiro
  email: ytsume@umich.edu, yasuhiro.tsume@merck.com
  organization: College of Pharmacy, The University of Michigan, Merck & Co., Inc
– sequence: 2
  givenname: Sanjaykumar
  surname: Patel
  fullname: Patel, Sanjaykumar
  organization: Merck & Co., Inc
– sequence: 3
  givenname: Nikoletta
  surname: Fotaki
  fullname: Fotaki, Nikoletta
  organization: Department of Pharmacy and Pharmacology, University of Bath
– sequence: 4
  givenname: Christel
  surname: Bergstrӧm
  fullname: Bergstrӧm, Christel
  organization: Department of Pharmacy, Uppsala University
– sequence: 5
  givenname: Gordon L.
  surname: Amidon
  fullname: Amidon, Gordon L.
  organization: College of Pharmacy, The University of Michigan
– sequence: 6
  givenname: James G.
  surname: Brasseur
  fullname: Brasseur, James G.
  organization: Aerospace Engineering Sciences, University of Colorado
– sequence: 7
  givenname: Deanna M.
  surname: Mudie
  fullname: Mudie, Deanna M.
  organization: Research and Development, Lonza
– sequence: 8
  givenname: Duxin
  surname: Sun
  fullname: Sun, Duxin
  organization: College of Pharmacy, The University of Michigan
– sequence: 9
  givenname: Marival
  surname: Bermejo
  fullname: Bermejo, Marival
  organization: Universidad Miguel Hernández de Elche
– sequence: 10
  givenname: Ping
  surname: Gao
  fullname: Gao, Ping
  organization: Abbvie, Inc
– sequence: 11
  givenname: Wei
  surname: Zhu
  fullname: Zhu, Wei
  organization: Merck & Co., Inc
– sequence: 12
  givenname: David C.
  surname: Sperry
  fullname: Sperry, David C.
  organization: Eli Lilly and Company
– sequence: 13
  givenname: Maria
  surname: Vertzoni
  fullname: Vertzoni, Maria
  organization: Department of Pharmacy, National and Kapodistrian University of Athens
– sequence: 14
  givenname: Neil
  surname: Parrott
  fullname: Parrott, Neil
  organization: F. Hoffmann-La Roche, Ltd., Roche Innovation Center
– sequence: 15
  givenname: Robert
  surname: Lionberger
  fullname: Lionberger, Robert
  organization: Food and Drug Administration
– sequence: 16
  givenname: Atsushi
  surname: Kambayashi
  fullname: Kambayashi, Atsushi
  organization: Astellas Pharma Inc
– sequence: 17
  givenname: Andre
  surname: Hermans
  fullname: Hermans, Andre
  organization: Merck & Co., Inc
– sequence: 18
  givenname: Xujin
  surname: Lu
  fullname: Lu, Xujin
  organization: Bristol-Myers Squibb Company
– sequence: 19
  givenname: Gregory E.
  surname: Amidon
  fullname: Amidon, Gregory E.
  organization: College of Pharmacy, The University of Michigan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30191341$$D View this record in MEDLINE/PubMed
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-364120$$DView record from Swedish Publication Index
BookMark eNp9kktv1DAQxy1URNuFD8AF-ciBgF9JHA5IpctCpUpFPMrRcpJJ1iWxg50s4svwWXG6D7UcerD8mN9_Zjwzp-jIOgsIPafkNWVEvgmUMSETQuNiGUn4I3RC05QkuaDZ0Z3zMToN4YYQzjilT9AxJ7SgXNAT9PfC4muzcfizh9pUo9kAXpoQXDeNxlmsbY2_mn7q9O31h_M_w9oN-AsMzo9v8UpXpjNjtNoWj-sohg10bujBjtg1-MrrDi_91OKV8wc3s9cZ3geNT3v2vXED-CbC2lbwFD1udBfg2W5foO-rD9_OPyWXVx8vzs8ukyoV6ZiUIISEQjABRdHUjJQZZJVkrNQ8p2VOZVqKvGaNpFDlaUkk04SXJXBRZppIvkCvtn7DbximUg3e9Nr_UU4btTTXZ8r5Vk2T4pmIlY_4uy0e2R7qKn425n5Pdd9izVq1bqOk5KSIXViglzsH3v2aIIyqN6GCrtMW3BQUo4SyPCtoHtEXd2Mdgux7GAG6BSrvQvDQHBBK1DwnajsnKs6JmudE8ajJ_9NUt010c7qme1DJdpWKUWwLXt24ydvYnAdE_wBWT9UU
CitedBy_id crossref_primary_10_3390_pharmaceutics13101729
crossref_primary_10_1016_j_ejps_2020_105517
crossref_primary_10_1248_cpb_c20_00247
crossref_primary_10_1016_j_apsb_2019_10_001
crossref_primary_10_1016_j_ejps_2020_105534
crossref_primary_10_1016_j_jddst_2019_01_035
crossref_primary_10_1016_j_ijpharm_2025_125227
Cites_doi 10.1002/jps.24391
10.1021/acs.molpharmaceut.6b00641
10.1586/17512433.2.2.195
10.1002/jps.24460
10.1016/j.ijpharm.2013.05.048
10.1016/j.ejpb.2016.06.004
10.1016/j.addr.2016.02.005
10.1002/jps.24108
10.1208/s12248-017-0060-1
10.1016/j.ejps.2015.05.013
10.1016/j.ejpb.2009.04.012
10.1016/j.ejps.2013.10.015
10.1016/j.xphs.2016.02.020
10.1023/A:1016212804288
10.1007/s11095-009-9927-x
10.1002/bdd.1803
10.1016/j.ejpb.2017.02.009
10.1021/acs.molpharmaceut.7b00425
10.1016/j.ejps.2014.01.009
10.1208/s12248-016-9957-3
10.1002/jps.24112
10.1016/j.ejpb.2015.03.009
10.1021/acs.molpharmaceut.5b00135
10.1007/s11095-015-1710-6
10.1016/j.ejps.2017.02.042
10.1016/j.ejpb.2016.03.024
10.1002/jps.24603
10.1016/j.xphs.2016.06.001
10.1021/acs.molpharmaceut.7b00426
10.1021/acs.molpharmaceut.6b01063
10.1016/j.xphs.2016.04.036
10.1021/acs.molpharmaceut.7b00552
10.1021/acs.molpharmaceut.6b01129
10.1021/acs.molpharmaceut.7b00121
10.1002/bdd.1800
10.1002/jps.24485
10.1002/1520-6017(200102)90:2<234::AID-JPS14>3.0.CO;2-V
10.1021/acs.molpharmaceut.7b00338
10.1016/j.xphs.2017.06.018
10.1016/j.xphs.2017.09.002
ContentType Journal Article
Copyright American Association of Pharmaceutical Scientists 2018
Copyright_xml – notice: American Association of Pharmaceutical Scientists 2018
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ADTPV
AOWAS
DF2
DOI 10.1208/s12248-018-0260-3
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
SwePub
SwePub Articles
SWEPUB Uppsala universitet
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1550-7416
EndPage 100
ExternalDocumentID oai_DiVA_org_uu_364120
PMC8830932
30191341
10_1208_s12248_018_0260_3
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: P30 CA046592
GroupedDBID ---
-56
-5G
-BR
-EM
-~C
.86
.VR
06C
06D
0R~
123
1N0
203
23M
29~
2J2
2JN
2JY
2KG
2KM
2LR
2~H
30V
406
408
40D
40E
53G
67N
6J9
6NX
875
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AAKDD
AANZL
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMJI
ACMLO
ACOKC
ACOMO
ACPIV
ACREN
ACSNA
ACZOJ
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADURQ
ADYFF
ADYOE
ADZKW
AEFQL
AEGAL
AEGNC
AEGXH
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFLOW
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGMZJ
AGQEE
AGQMX
AGRTI
AGWZB
AGYKE
AHAVH
AHBYD
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJRNO
AJZVZ
AKMHD
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AOCGG
ARMRJ
AXYYD
B-.
BA0
BDATZ
BGNMA
CS3
CSCUP
DDRTE
DIK
DNIVK
DPUIP
E3Z
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
ESBYG
F5P
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GX1
H13
HG6
HH5
HMJXF
HRMNR
HZ~
IJ-
IKXTQ
IWAJR
IXC
IXD
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KOV
KPH
LLZTM
M4Y
MA-
MK0
NPVJJ
NQJWS
O9-
O93
O9I
O9J
P6G
PF0
PT4
PT5
QOR
QOS
R89
R9I
ROL
RPM
RPX
RSV
S16
S27
S3A
S3B
SAP
SBL
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
TSG
TSV
TUC
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK8
XSB
YLTOR
Z45
Z7U
Z7V
Z7W
Z7X
Z81
Z83
Z87
ZMTXR
ZOVNA
~A9
-Y2
2VQ
4.4
AAPKM
AARHV
AAYXX
ABBRH
ABDBE
ABFSG
ABULA
ACMFV
ACSTC
ADBBV
ADQRH
AEBTG
AEZWR
AFDZB
AFGCZ
AFHIU
AFOHR
AGJBK
AHPBZ
AHSBF
AHWEU
AIXLP
AJBLW
AOIJS
ATHPR
AYFIA
BAWUL
C1A
CAG
CITATION
COF
EN4
HYE
IAO
IEA
IHR
LGEZI
LOTEE
NADUK
NU0
NXXTH
S1Z
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ADTPV
AOWAS
DF2
ID FETCH-LOGICAL-c545t-be448e9424e99fd20b6e6c822ba371b7185b47d2f81ec75b082a03bbe34b6a083
IEDL.DBID U2A
ISSN 1550-7416
IngestDate Thu Aug 21 06:56:50 EDT 2025
Thu Aug 21 14:07:12 EDT 2025
Fri Jul 11 05:02:19 EDT 2025
Mon Jul 21 06:02:21 EDT 2025
Thu Apr 24 23:11:16 EDT 2025
Tue Jul 01 01:45:14 EDT 2025
Fri Feb 21 02:33:45 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords prediction
formulation prediction
simulation
dissolution
in vivo prediction
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c545t-be448e9424e99fd20b6e6c822ba371b7185b47d2f81ec75b082a03bbe34b6a083
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/8830932
PMID 30191341
PQID 2101276917
PQPubID 23479
PageCount 1
ParticipantIDs swepub_primary_oai_DiVA_org_uu_364120
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8830932
proquest_miscellaneous_2101276917
pubmed_primary_30191341
crossref_primary_10_1208_s12248_018_0260_3
crossref_citationtrail_10_1208_s12248_018_0260_3
springer_journals_10_1208_s12248_018_0260_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20180906
PublicationDateYYYYMMDD 2018-09-06
PublicationDate_xml – month: 9
  year: 2018
  text: 20180906
  day: 6
PublicationDecade 2010
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: United States
PublicationSubtitle An Official Journal of the American Association of Pharmaceutical Scientists
PublicationTitle The AAPS journal
PublicationTitleAbbrev AAPS J
PublicationTitleAlternate AAPS J
PublicationYear 2018
Publisher Springer International Publishing
Publisher_xml – name: Springer International Publishing
References Matsui, Tsume, Amidon, Amidon (CR27) 2015; 12
Tsume, Mudie, Langguth, Amidon, Amidon (CR15) 2014; 57
Stewart, Grass, Brodeur, Goodwin, Morgen, Friesen, Vodak (CR16) 2017; 14
Riethorst, Mols, Duchateau, Tack, Brouwers, Augustijns (CR9) 2016; 105
Shi, Erickson, Jayasankar, Lu, Marsh, Menon, Gao (CR21) 2016; 105
Hasselbalch (CR10) 1916; 78
Amidon, Lennernas, Shah, Crison (CR13) 1995; 12
Tsume, Matsui, Searls, Takeuchi, Amidon, Sun, Amidon (CR24) 2017; 102
Bittner, McIntyre, Tian, Tang, Shah, Phuapradit (CR39) 2012; 67
Cristofoletti, Dressman (CR5) 2017; 106
Stewart, Grass, Mudie, Morgen, Friesen, Vodak (CR17) 2017; 14
Koenigsknecht, Baker, Wen, Frances, Zhang, Yu, Zhao, Tsume, Pai, Bleske, Zhang, Lionberger, Lee, Amidon, Hasler, Sun (CR19) 2017; 14
CR31
Xu, Vela, Shi, Marroum, Gao (CR22) 2017; 14
Tsume, Takeuchi, Matsui, Amidon, Amidon (CR25) 2015; 76
Georgaka, Butler, Kesisoglou, Reppas, Vertzoni (CR36) 2017; 14
Bergstrom, Holm, Jorgensen, Andersson, Artursson, Beato (CR8) 2014; 57
Fotaki, Aivaliotis, Butler, Dressman, Fischbach, Hempenstall, Klein, Reppas (CR38) 2009; 73
Yu, Baker, Fioritto, Wang, Luo, Li, Wen, Bly, Tsume, Koenigsknecht, Zhang, Lionberger, Amidon, Hasler, Sun (CR18) 2017; 14
Parrott, Yu, Takano, Nakamura, Morcos (CR42) 2016; 18
Matsui, Tsume, Amidon, Amidon (CR28) 2016; 105
Cristofoletti, Dressman (CR3) 2016; 105
Tsume, Langguth, Garcia-Arieta, Amidon (CR30) 2012; 33
Krieg, Taghavi, Amidon, Amidon (CR1) 2014; 103
Litou, Vertzoni, Xu, Kesisoglou, Reppas (CR6) 2017; 115
Fotaki (CR37) 2009; 2
Reppas, Karatza, Goumas, Markopoulos, Vertzoni (CR32) 2015; 32
Stillhart, Parrott, Lindenberg, Chalus, Bentley, Szepes (CR41) 2017; 19
Markopoulos, Vertzoni, Symillides, Kesisoglou, Reppas (CR34) 2015; 104
Cristofoletti, Dressman (CR4) 2016; 103
Mudie, Shi, Ping, Gao, Amidon, Amidon (CR20) 2012; 33
CR23
Markopoulos, Andreas, Vertzoni, Dressman, Reppas (CR35) 2015; 93
Hens, Tsume, Bermejo, Paixao, Koenigsknecht, Baker, Hasler, Lionberger, Fan, Dickens, Shedden, Wen, Wysocki, Loebenberg, Lee, Frances, Amidon, Yu, Benninghoff, Salehi, Talattof, Sun, Amidon (CR7) 2017; 14
Diakidou, Vertzoni, Goumas, Soderlind, Abrahamsson, Dressman (CR33) 2009; 26
Tomaszewska, Karki, Shur, Price, Fotaki (CR40) 2013; 453
Sugano, Terada (CR14) 2015; 104
Krieg, Taghavi, Amidon, Amidon (CR2) 2015; 104
Jain, Yalkowsky (CR11) 2001; 90
Matsui, Tsume, Takeuchi, Searls, Amidon (CR29) 2017; 14
Takeuchi, Tsume, Amidon, Amidon (CR26) 2014; 103
Bergstrom, Charman, Porter (CR12) 2016; 101
R Cristofoletti (260_CR3) 2016; 105
C Litou (260_CR6) 2017; 115
K Matsui (260_CR27) 2015; 12
Y Tsume (260_CR15) 2014; 57
B Bittner (260_CR39) 2012; 67
K Sugano (260_CR14) 2015; 104
N Fotaki (260_CR38) 2009; 73
K Matsui (260_CR28) 2016; 105
CAS Bergstrom (260_CR12) 2016; 101
H Xu (260_CR22) 2017; 14
AM Stewart (260_CR17) 2017; 14
C Reppas (260_CR32) 2015; 32
260_CR31
I Tomaszewska (260_CR40) 2013; 453
BJ Krieg (260_CR1) 2014; 103
KA Hasselbalch (260_CR10) 1916; 78
A Diakidou (260_CR33) 2009; 26
CA Bergstrom (260_CR8) 2014; 57
AM Stewart (260_CR16) 2017; 14
C Markopoulos (260_CR35) 2015; 93
C Markopoulos (260_CR34) 2015; 104
D Riethorst (260_CR9) 2016; 105
S Takeuchi (260_CR26) 2014; 103
R Cristofoletti (260_CR5) 2017; 106
A Yu (260_CR18) 2017; 14
GL Amidon (260_CR13) 1995; 12
BJ Krieg (260_CR2) 2015; 104
Y Shi (260_CR21) 2016; 105
Y Tsume (260_CR25) 2015; 76
N Fotaki (260_CR37) 2009; 2
NJ Parrott (260_CR42) 2016; 18
260_CR23
Y Tsume (260_CR30) 2012; 33
MJ Koenigsknecht (260_CR19) 2017; 14
R Cristofoletti (260_CR4) 2016; 103
N Jain (260_CR11) 2001; 90
C Stillhart (260_CR41) 2017; 19
DM Mudie (260_CR20) 2012; 33
Y Tsume (260_CR24) 2017; 102
D Georgaka (260_CR36) 2017; 14
K Matsui (260_CR29) 2017; 14
B Hens (260_CR7) 2017; 14
References_xml – volume: 104
  start-page: 2777
  issue: 9
  year: 2015
  end-page: 2788
  ident: CR14
  article-title: Rate- and Eextent-lLimiting fFactors of oOral dDrug aAbsorption: tTheory and aApplications
  publication-title: J Pharm Sci
  doi: 10.1002/jps.24391
– volume: 14
  start-page: 345
  issue: 2
  year: 2017
  end-page: 358
  ident: CR18
  article-title: Measurement of in vivo gastrointestinal release and dissolution of three locally acting mesalamine formulations in regions of the human gastrointestinal tract
  publication-title: Mol Pharm
  doi: 10.1021/acs.molpharmaceut.6b00641
– volume: 2
  start-page: 195
  issue: 2
  year: 2009
  end-page: 208
  ident: CR37
  article-title: Pros and cons of methods used for the prediction of oral drug absorption
  publication-title: Expert Rev Clin Pharmacol
  doi: 10.1586/17512433.2.2.195
– volume: 104
  start-page: 2894
  issue: 9
  year: 2015
  end-page: 2904
  ident: CR2
  article-title: In vivo predictive dissolution: comparing the effect of bicarbonate and phosphate buffer on the dissolution of weak acids and weak bases
  publication-title: J Pharm Sci
  doi: 10.1002/jps.24460
– volume: 453
  start-page: 380
  issue: 2
  year: 2013
  end-page: 388
  ident: CR40
  article-title: Pharmaceutical characterisation and evaluation of cocrystals: importance of in vitro dissolution conditions and type of coformer
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2013.05.048
– volume: 105
  start-page: 134
  year: 2016
  end-page: 140
  ident: CR3
  article-title: FaSSIF-V3, but not compendial media, appropriately detects differences in the peak and extent of exposure between reference and test formulations of ibuprofen
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/j.ejpb.2016.06.004
– volume: 101
  start-page: 6
  year: 2016
  end-page: 21
  ident: CR12
  article-title: Computational prediction of formulation strategies for beyond-rule-of-5 compounds
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2016.02.005
– volume: 103
  start-page: 3473
  issue: 11
  year: 2014
  end-page: 3490
  ident: CR1
  article-title: In vivo predictive dissolution: transport analysis of the CO2, bicarbonate in vivo buffer system
  publication-title: J Pharm Sci
  doi: 10.1002/jps.24108
– volume: 19
  start-page: 827
  issue: 3
  year: 2017
  end-page: 836
  ident: CR41
  article-title: Characterising drug release from immediate-release formulations of a poorly soluble compound, basmisanil, through absorption modelling and dissolution testing
  publication-title: AAPS J
  doi: 10.1208/s12248-017-0060-1
– volume: 76
  start-page: 203
  year: 2015
  end-page: 212
  ident: CR25
  article-title: In vitro dissolution methodology, mini-gastrointestinal simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib
  publication-title: Eur J Pharm Sci
  doi: 10.1016/j.ejps.2015.05.013
– volume: 73
  start-page: 115
  issue: 1
  year: 2009
  end-page: 120
  ident: CR38
  article-title: A comparative study of different release apparatus in generating in vitro-in vivo correlations for extended release formulations
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/j.ejpb.2009.04.012
– volume: 57
  start-page: 173
  year: 2014
  end-page: 199
  ident: CR8
  article-title: Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs
  publication-title: Eur J Pharm Sci
  doi: 10.1016/j.ejps.2013.10.015
– volume: 105
  start-page: 2804
  issue: 9
  year: 2016
  end-page: 2814
  ident: CR28
  article-title: The evaluation of in vitro drug dissolution of commercially available oral dosage forms for itraconazole in gastrointestinal simulator with biorelevant media
  publication-title: J Pharm Sci
  doi: 10.1016/j.xphs.2016.02.020
– volume: 12
  start-page: 413
  issue: 3
  year: 1995
  end-page: 420
  ident: CR13
  article-title: A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability
  publication-title: Pharm Res
  doi: 10.1023/A:1016212804288
– volume: 26
  start-page: 2141
  issue: 9
  year: 2009
  end-page: 2151
  ident: CR33
  article-title: Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults
  publication-title: Pharm Res
  doi: 10.1007/s11095-009-9927-x
– volume: 67
  start-page: 233
  issue: 3
  year: 2012
  end-page: 241
  ident: CR39
  article-title: Phase I clinical study to select a novel oral formulation for ibandronate containing the excipient sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC)
  publication-title: Pharmazie
– volume: 33
  start-page: 378
  issue: 7
  year: 2012
  end-page: 402
  ident: CR20
  article-title: Mechanistic analysis of solute transport in an in vitro physiological two-phase dissolution apparatus
  publication-title: Biopharm Drug Dispos
  doi: 10.1002/bdd.1803
– volume: 115
  start-page: 94
  year: 2017
  end-page: 101
  ident: CR6
  article-title: The impact of reduced gastric acid secretion on dissolution of salts of weak bases in the fasted upper gastrointestinal lumen: data in biorelevant media and in human aspirates
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/j.ejpb.2017.02.009
– volume: 14
  start-page: 4295
  issue: 12
  year: 2017
  end-page: 4304
  ident: CR19
  article-title: In vivo dissolution and systemic absorption of immediate release ibuprofen in human gastrointestinal tract under fed and fasted conditions
  publication-title: Mol Pharm
  doi: 10.1021/acs.molpharmaceut.7b00425
– volume: 57
  start-page: 152
  year: 2014
  end-page: 163
  ident: CR15
  article-title: The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC
  publication-title: Eur J Pharm Sci
  doi: 10.1016/j.ejps.2014.01.009
– volume: 18
  start-page: 1464
  issue: 6
  year: 2016
  end-page: 1474
  ident: CR42
  article-title: Physiologically based absorption modeling to explore the impact of food and gastric pH changes on the pharmacokinetics of alectinib
  publication-title: AAPS J
  doi: 10.1208/s12248-016-9957-3
– ident: CR23
– volume: 103
  start-page: 3416
  issue: 11
  year: 2014
  end-page: 3422
  ident: CR26
  article-title: Evaluation of a three compartment in vitro gastrointestinal simulator dissolution apparatus to predict in vivo dissolution
  publication-title: J Pharm Sci
  doi: 10.1002/jps.24112
– volume: 93
  start-page: 173
  year: 2015
  end-page: 182
  ident: CR35
  article-title: In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: choosing the appropriate test media
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/j.ejpb.2015.03.009
– volume: 12
  start-page: 2418
  issue: 7
  year: 2015
  end-page: 2428
  ident: CR27
  article-title: In vitro dissolution of fluconazole and dipyridamole in gastrointestinal simulator (GIS), predicting in vivo dissolution and drug-drug interaction caused by acid-reducing agents
  publication-title: Mol Pharm
  doi: 10.1021/acs.molpharmaceut.5b00135
– volume: 32
  start-page: 3338
  issue: 10
  year: 2015
  end-page: 3349
  ident: CR32
  article-title: Characterization of contents of distal ileum and cecum to which drugs/drug products are exposed during bioavailability/bioequivalence studies in healthy adults
  publication-title: Pharm Res
  doi: 10.1007/s11095-015-1710-6
– volume: 102
  start-page: 126
  year: 2017
  end-page: 139
  ident: CR24
  article-title: The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: gastrointestinal simulator (GIS)
  publication-title: Eur J Pharm Sci
  doi: 10.1016/j.ejps.2017.02.042
– volume: 103
  start-page: 104
  year: 2016
  end-page: 108
  ident: CR4
  article-title: Matching phosphate and maleate buffer systems for dissolution of weak acids: equivalence in terms of buffer capacity of bulk solution or surface pH?
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/j.ejpb.2016.03.024
– volume: 105
  start-page: 673
  issue: 2
  year: 2016
  end-page: 681
  ident: CR9
  article-title: Characterization of human duodenal fluids in fasted and fed state conditions
  publication-title: J Pharm Sci
  doi: 10.1002/jps.24603
– ident: CR31
– volume: 106
  start-page: 92
  issue: 1
  year: 2017
  end-page: 99
  ident: CR5
  article-title: Dissolution methods to increasing discriminatory power of in vitro dissolution testing for ibuprofen free acid and its salts
  publication-title: J Pharm Sci
  doi: 10.1016/j.xphs.2016.06.001
– volume: 14
  start-page: 4281
  issue: 12
  year: 2017
  end-page: 4294
  ident: CR7
  article-title: Low buffer capacity and alternating motility along the human gastrointestinal tract: implications for in vivo dissolution and absorption of ionizable drugs
  publication-title: Mol Pharm
  doi: 10.1021/acs.molpharmaceut.7b00426
– volume: 14
  start-page: 1181
  issue: 4
  year: 2017
  end-page: 1189
  ident: CR29
  article-title: Utilization of gastrointestinal simulator, an in vivo predictive dissolution methodology, coupled with computational approach to forecast oral absorption of dipyridamole
  publication-title: Mol Pharm
  doi: 10.1021/acs.molpharmaceut.6b01063
– volume: 105
  start-page: 2886
  issue: 9
  year: 2016
  end-page: 2895
  ident: CR21
  article-title: Assessing supersaturation and its impact on in vivo bioavailability of a low-solubility compound ABT-072 with a dual pH, two-phase dissolution method
  publication-title: J Pharm Sci
  doi: 10.1016/j.xphs.2016.04.036
– volume: 14
  start-page: 3801
  issue: 11
  year: 2017
  end-page: 3814
  ident: CR22
  article-title: In vitro characterization of ritonavir drug products and correlation to human in vivo performance
  publication-title: Mol Pharm
  doi: 10.1021/acs.molpharmaceut.7b00552
– volume: 14
  start-page: 4181
  issue: 12
  year: 2017
  end-page: 4191
  ident: CR36
  article-title: Evaluation of dissolution in the lower intestine and its impact on the absorption process of high dose low solubility drugs
  publication-title: Mol Pharm
  doi: 10.1021/acs.molpharmaceut.6b01129
– volume: 14
  start-page: 2032
  issue: 6
  year: 2017
  end-page: 2046
  ident: CR17
  article-title: Development of a biorelevant, material-sparing membrane flux test for rapid screening of bioavailability-enhancing drug product formulations
  publication-title: Mol Pharm
  doi: 10.1021/acs.molpharmaceut.7b00121
– volume: 33
  start-page: 366
  issue: 7
  year: 2012
  end-page: 377
  ident: CR30
  article-title: In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen
  publication-title: Biopharm Drug Dispos
  doi: 10.1002/bdd.1800
– volume: 104
  start-page: 2986
  issue: 9
  year: 2015
  end-page: 2997
  ident: CR34
  article-title: Two-stage single-compartment models to evaluate dissolution in the lower intestine
  publication-title: J Pharm Sci
  doi: 10.1002/jps.24485
– volume: 78
  start-page: 112
  year: 1916
  end-page: 144
  ident: CR10
  article-title: Die Berechnung der Wasserstoffzahl des Blutes aus der freien und gebundenen Kohlensäure desselben, und die Sauerstoffbindung des Blutes als Funktion der Wasserstoffzahl
  publication-title: Biochemische Z
– volume: 90
  start-page: 234
  issue: 2
  year: 2001
  end-page: 252
  ident: CR11
  article-title: Estimation of the aqueous solubility I: application to organic nonelectrolytes
  publication-title: J Pharm Sci
  doi: 10.1002/1520-6017(200102)90:2<234::AID-JPS14>3.0.CO;2-V
– volume: 14
  start-page: 2437
  issue: 7
  year: 2017
  end-page: 2449
  ident: CR16
  article-title: Impact of drug-rich colloids of itraconazole and HPMCAS on membrane flux in vitro and oral bioavailability in rats
  publication-title: Mol Pharm
  doi: 10.1021/acs.molpharmaceut.7b00338
– volume: 73
  start-page: 115
  issue: 1
  year: 2009
  ident: 260_CR38
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/j.ejpb.2009.04.012
– volume: 14
  start-page: 3801
  issue: 11
  year: 2017
  ident: 260_CR22
  publication-title: Mol Pharm
  doi: 10.1021/acs.molpharmaceut.7b00552
– volume: 2
  start-page: 195
  issue: 2
  year: 2009
  ident: 260_CR37
  publication-title: Expert Rev Clin Pharmacol
  doi: 10.1586/17512433.2.2.195
– volume: 103
  start-page: 3473
  issue: 11
  year: 2014
  ident: 260_CR1
  publication-title: J Pharm Sci
  doi: 10.1002/jps.24108
– volume: 105
  start-page: 2804
  issue: 9
  year: 2016
  ident: 260_CR28
  publication-title: J Pharm Sci
  doi: 10.1016/j.xphs.2016.02.020
– ident: 260_CR23
  doi: 10.1016/j.xphs.2017.06.018
– volume: 115
  start-page: 94
  year: 2017
  ident: 260_CR6
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/j.ejpb.2017.02.009
– volume: 26
  start-page: 2141
  issue: 9
  year: 2009
  ident: 260_CR33
  publication-title: Pharm Res
  doi: 10.1007/s11095-009-9927-x
– volume: 101
  start-page: 6
  year: 2016
  ident: 260_CR12
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2016.02.005
– volume: 14
  start-page: 345
  issue: 2
  year: 2017
  ident: 260_CR18
  publication-title: Mol Pharm
  doi: 10.1021/acs.molpharmaceut.6b00641
– volume: 14
  start-page: 4181
  issue: 12
  year: 2017
  ident: 260_CR36
  publication-title: Mol Pharm
  doi: 10.1021/acs.molpharmaceut.6b01129
– ident: 260_CR31
  doi: 10.1016/j.xphs.2017.09.002
– volume: 14
  start-page: 1181
  issue: 4
  year: 2017
  ident: 260_CR29
  publication-title: Mol Pharm
  doi: 10.1021/acs.molpharmaceut.6b01063
– volume: 14
  start-page: 4295
  issue: 12
  year: 2017
  ident: 260_CR19
  publication-title: Mol Pharm
  doi: 10.1021/acs.molpharmaceut.7b00425
– volume: 90
  start-page: 234
  issue: 2
  year: 2001
  ident: 260_CR11
  publication-title: J Pharm Sci
  doi: 10.1002/1520-6017(200102)90:2<234::AID-JPS14>3.0.CO;2-V
– volume: 57
  start-page: 173
  year: 2014
  ident: 260_CR8
  publication-title: Eur J Pharm Sci
  doi: 10.1016/j.ejps.2013.10.015
– volume: 102
  start-page: 126
  year: 2017
  ident: 260_CR24
  publication-title: Eur J Pharm Sci
  doi: 10.1016/j.ejps.2017.02.042
– volume: 78
  start-page: 112
  year: 1916
  ident: 260_CR10
  publication-title: Biochemische Z
– volume: 12
  start-page: 413
  issue: 3
  year: 1995
  ident: 260_CR13
  publication-title: Pharm Res
  doi: 10.1023/A:1016212804288
– volume: 104
  start-page: 2777
  issue: 9
  year: 2015
  ident: 260_CR14
  publication-title: J Pharm Sci
  doi: 10.1002/jps.24391
– volume: 14
  start-page: 2032
  issue: 6
  year: 2017
  ident: 260_CR17
  publication-title: Mol Pharm
  doi: 10.1021/acs.molpharmaceut.7b00121
– volume: 19
  start-page: 827
  issue: 3
  year: 2017
  ident: 260_CR41
  publication-title: AAPS J
  doi: 10.1208/s12248-017-0060-1
– volume: 57
  start-page: 152
  year: 2014
  ident: 260_CR15
  publication-title: Eur J Pharm Sci
  doi: 10.1016/j.ejps.2014.01.009
– volume: 18
  start-page: 1464
  issue: 6
  year: 2016
  ident: 260_CR42
  publication-title: AAPS J
  doi: 10.1208/s12248-016-9957-3
– volume: 93
  start-page: 173
  year: 2015
  ident: 260_CR35
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/j.ejpb.2015.03.009
– volume: 67
  start-page: 233
  issue: 3
  year: 2012
  ident: 260_CR39
  publication-title: Pharmazie
– volume: 104
  start-page: 2986
  issue: 9
  year: 2015
  ident: 260_CR34
  publication-title: J Pharm Sci
  doi: 10.1002/jps.24485
– volume: 14
  start-page: 2437
  issue: 7
  year: 2017
  ident: 260_CR16
  publication-title: Mol Pharm
  doi: 10.1021/acs.molpharmaceut.7b00338
– volume: 103
  start-page: 104
  year: 2016
  ident: 260_CR4
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/j.ejpb.2016.03.024
– volume: 76
  start-page: 203
  year: 2015
  ident: 260_CR25
  publication-title: Eur J Pharm Sci
  doi: 10.1016/j.ejps.2015.05.013
– volume: 103
  start-page: 3416
  issue: 11
  year: 2014
  ident: 260_CR26
  publication-title: J Pharm Sci
  doi: 10.1002/jps.24112
– volume: 106
  start-page: 92
  issue: 1
  year: 2017
  ident: 260_CR5
  publication-title: J Pharm Sci
  doi: 10.1016/j.xphs.2016.06.001
– volume: 105
  start-page: 2886
  issue: 9
  year: 2016
  ident: 260_CR21
  publication-title: J Pharm Sci
  doi: 10.1016/j.xphs.2016.04.036
– volume: 104
  start-page: 2894
  issue: 9
  year: 2015
  ident: 260_CR2
  publication-title: J Pharm Sci
  doi: 10.1002/jps.24460
– volume: 33
  start-page: 366
  issue: 7
  year: 2012
  ident: 260_CR30
  publication-title: Biopharm Drug Dispos
  doi: 10.1002/bdd.1800
– volume: 453
  start-page: 380
  issue: 2
  year: 2013
  ident: 260_CR40
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2013.05.048
– volume: 105
  start-page: 673
  issue: 2
  year: 2016
  ident: 260_CR9
  publication-title: J Pharm Sci
  doi: 10.1002/jps.24603
– volume: 12
  start-page: 2418
  issue: 7
  year: 2015
  ident: 260_CR27
  publication-title: Mol Pharm
  doi: 10.1021/acs.molpharmaceut.5b00135
– volume: 105
  start-page: 134
  year: 2016
  ident: 260_CR3
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/j.ejpb.2016.06.004
– volume: 32
  start-page: 3338
  issue: 10
  year: 2015
  ident: 260_CR32
  publication-title: Pharm Res
  doi: 10.1007/s11095-015-1710-6
– volume: 14
  start-page: 4281
  issue: 12
  year: 2017
  ident: 260_CR7
  publication-title: Mol Pharm
  doi: 10.1021/acs.molpharmaceut.7b00426
– volume: 33
  start-page: 378
  issue: 7
  year: 2012
  ident: 260_CR20
  publication-title: Biopharm Drug Dispos
  doi: 10.1002/bdd.1803
SSID ssj0032311
Score 2.2660737
SourceID swepub
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 100
SubjectTerms Administration, Oral
Biochemistry
Biomedical and Life Sciences
Biomedicine
Biotechnology
Chemistry, Pharmaceutical
Computer Simulation
Congresses as Topic
dissolution
Drug Development
Drug Liberation
formulation prediction
Gastrointestinal Absorption
Gastrointestinal Contents - chemistry
Humans
Hydrodynamics
Hydrogen-Ion Concentration
in vivo prediction
Meeting Report
Models, Biological
Pharmaceutical Preparations - administration & dosage
Pharmaceutical Preparations - chemistry
Pharmacology/Toxicology
Pharmacy
simulation
Solubility
Title In Vivo Predictive Dissolution and Simulation Workshop Report: Facilitating the Development of Oral Drug Formulation and the Prediction of Oral Bioperformance
URI https://link.springer.com/article/10.1208/s12248-018-0260-3
https://www.ncbi.nlm.nih.gov/pubmed/30191341
https://www.proquest.com/docview/2101276917
https://pubmed.ncbi.nlm.nih.gov/PMC8830932
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-364120
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELfY9sIL4ptuUB0S7AEWkcROnPBW6LoBAiqxTuXJshO7i8SSqmmQ9s_wt3LOVylDk3jIS-KzE935_HPu7mdCXhgu3VQHkcN9xh0W45yLTWScJI5MQrXkgWerkT9_CU9n7OM8mLd13GWX7d6FJGtPXTMguNGb0saAbOIVXgjCHbpD9gK7dUcjnvmjzv1SBCxeG778p9j2AnQNVV5PjuwjpH-xidYr0OQuudNCRxg1ur5Hbun8PjmcNtzTV0dwtimlKo_gEKYbVuqrB-TXhxzOs58FTFc2NmO9HIyz3vRA5il8yy7b07zA_kQvL4olNAj9LUxk0hJ65wtA1Ah_pBtBYeArfgWMV9UCJgiDu25sr7ZxNyje6tq-y4rlpmrhIZlNjs_enzrt4QxOgqBr7SiNGzsdM5_pODap76pQhwnCDSUp9xQueYFiPPVN5OmEBwqhhnSpUpoyFUoEfo_Ibl7k-gkB6urAyCSmgUlZ4EppIh250jWaIlxVdEDcTmMiaZnL7QEaP4TdwaCSRaNkgUoWVskCRV71IsuGtuOmxs87MxA4uWzEROa6qErhW_YzHuKWdkAeN2bRd4ee0WYteAPCtwymb2CJu7ef5NlFTeAdRTb-7A_I6860ROs5ypve8mVjfVsDjLPzkShWC1FVgoYMRff_q9cDctuv54blonhKdterSj9DmLVWQ7I3Ovn-6XhIdk7m3rCeZL8BI4snyg
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLZgPMAL4k4Zl4MEe4BFS2IncXgrlKqDbVSinfZm2YndRWJJ1TRI-zP8Vo5zK2VoEg95SXzsROfizznHnwl5YyLppjrgTuSzyGEx-lxsuHGSmJuEahkFnt2NfHwSTubsy1lw1u7jLrtq9y4lWUfqmgHB5QelzQHZwiu8EIQ79Ca5hViA2zquuT_swi9FwOK16ct_im1PQFdQ5dXiyD5D-hebaD0Dje-Ruy10hGGj6_vkhs4fkL1pwz19uQ-zzVaqch_2YLphpb58SH4d5nCa_SxgurK5GRvlYJT1pgcyT-F7dtGe5gX2J3p5XiyhQegfYCyTltA7XwCiRvij3AgKA9_wK2C0qhYwRhjcdWN7tY27QfFW1_ZjViw3uxYekfn48-zTxGkPZ3ASBF1rR2lc2OmY-UzHsUl9V4U6TBBuKEkjT-GUFygWpb7hnk6iQCHUkC5VSlOmQonA7zHZyYtcPyVAXR0YmcQ0MCkLXCkN19yVrtEU4aqiA-J2GhNJy1xuD9D4IewKBpUsGiULVLKwShYo8q4XWTa0Hdc1ft2ZgUDnshkTmeuiKoVv2c-iEJe0A_KkMYu-O4yMtmrBG5Boy2D6Bpa4e_tJnp3XBN6c2_yzPyDvO9MSbeQor3vLt431bQ0wyk6HolgtRFUJGjIUffZfvb4ityez4yNxdHjydZfc8Ws_sbwUz8nOelXpFwi51upl7WK_AQVqKDg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSIgL4s3yHCToARo1ifNwuC0sUcujrES36s2yE3sbCZLVZoPUP8NvZWbzWJaiShxySTx2ohmPP2fG3zD20sbKzU0onNgPYidIcM4lVlgnS4TNuFFx6NFp5C9H0cEs-HgannZ1Tus-270PSbZnGoilqVztL3LbsiG4Yr-meBAlYeGFgNzhV9k19MYemfXMH_eumCN48bpQ5j_FthejCwjzYqLkEC39i1l0vRqlt9jNDkbCuNX7bXbFlHfY7rTloT7fg-PNsap6D3ZhumGoPr_Lfh2WcFL8rGC6pDgNeTyYFIMZgipz-Fb86Cp7Af1Qr8-qBbRo_S2kKuvIvcs5IIKEP1KPoLLwFb8CJstmDilC4r4b6pUa94Pirb7tu6JabE4w3GOz9MPx-wOnK9TgZAjAVo42uMkzSeAHJkls7rs6MlGG0EMrHnsal79QB3HuW-GZLA41wg7lcq0ND3SkEATeZztlVZqHDLhrQquyhIc2D0JXKSuMcJVrDUfoqvmIub3GZNaxmFMxje-SdjOoZNkqWaKSJSlZosjrQWTRUnhc1vhFbwYSJxpFT1RpqqaWPjGhxRFub0fsQWsWQ3foJSmDwRuxeMtghgZE4r39pCzO1mTeQlAs2h-xN71pyc6L1Je95avW-rYGmBQnY1kt57JpJI8CFH30X70-Z9enk1R-Pjz69Jjd8NfThCgqnrCd1bIxTxF9rfSz9Qz7DUVrLHQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+Vivo+Predictive+Dissolution+and+Simulation+Workshop+Report%3A+Facilitating+the+Development+of+Oral+Drug+Formulation+and+the+Prediction+of+Oral+Bioperformance&rft.jtitle=The+AAPS+journal&rft.au=Tsume%2C+Yasuhiro&rft.au=Patel%2C+Sanjaykumar&rft.au=Fotaki%2C+Nikoletta&rft.au=Bergstr%C3%B6m%2C+Christel&rft.date=2018-09-06&rft.eissn=1550-7416&rft.volume=20&rft.issue=6&rft.spage=100&rft.epage=100&rft_id=info:doi/10.1208%2Fs12248-018-0260-3&rft_id=info%3Apmid%2F30191341&rft.externalDocID=PMC8830932
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1550-7416&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1550-7416&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1550-7416&client=summon